or
forgot password
  • cancer clinical trials in beaverton, OR

  • DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    OHSU Knight Cancer Institute Hematology Oncology
    Beaverton, Oregon 97006
    Urothelial Carcinoma